Dear Dr. Roach: I am a 75-year-old man with an elevated A1C level; I was diagnosed with prediabetes. I feel healthy but have struggled to lose weight. I was wondering what your feeling are on using a ...

NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, announced the publication of a paper in the journal The Lancet ...

A continuous glucose monitor (CGM) can tell you when my glucose spikes, but not that I delayed correcting it because I was in a high-stakes meeting. It can record the number after I under-bolused for ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...

Apple has suffered a major defeat in its long-term legal dispute with the medtech firm Masimo and has been ordered to pay $634 million in damages. As the Daily Journal reports, a federal jury agreed ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

In the latest chapter of the long-running legal war between Apple and medical tech company Masimo, a federal jury in California has ordered Apple to pay $634 million in damages. The jury found that ...

University Hospitals recently announced the expansion of remote patient monitoring capabilities with the goals of enhancing patient safety, improving the patient experience, and increasing operational ...

A U.S. jury ruled on November 15, 2025, that Apple must pay Masimo $634 million in a patent infringement case over smartwatch technology, awarding Masimo a major victory after years of litigation.

Massimo develops and markets noninvasive patient monitoring technologies, including pulse oximetry, brain function monitoring, capnography, and hospital automation solutions. Generates revenue through ...

A federal jury in California has sided with Masimo in a patent battle with Apple over Apple Watch’s blood oxygen feature. The jury awarded Masimo $634 million in damages and concluded that Apple ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology. Reuters reports the jury found ...